World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
16586
World Ranking
19225
National Ranking
9578

Overview

Hau C. Kwaan is affiliated with Northwestern University in the United States and has contributed extensively to the field of medicine, with a focus on neurology, infectious diseases, critical care and intensive care medicine, epidemiology, and pulmonary and respiratory medicine. Their research spans a variety of topics related to trauma, hemostasis, coagulopathy, resuscitation, COVID-19 clinical research, intracerebral and subarachnoid hemorrhage, long-term effects of COVID-19, blood properties and coagulation, acute ischemic stroke management, and blood transfusion and management.

Kwaan's recent publications include:

  • Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae (2020, Seminars in Thrombosis and Hemostasis)
  • The Central Role of Fibrinolytic Response in COVID-19-A Hematologist's Perspective (2021, International Journal of Molecular Sciences)
  • Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices (2022, Journal of Clinical Medicine)
  • Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Severity of Clinical Illness (2022, Seminars in Thrombosis and Hemostasis)
  • Immuno-Thrombotic Complications of COVID-19: Implications for Timing of Surgery and Anticoagulation (2022, Frontiers in Surgery)

Kwaan frequently collaborates with several coauthors, including Mark Walsh, Connor M. Bunch, Hunter B. Moore, Ernest E. Moore, and Anthony V. Thomas.

Their work is commonly published in venues such as Seminars in Thrombosis and Hemostasis, Journal of Clinical Medicine, International Journal of Molecular Sciences, Frontiers in Immunology, and Transfusion.

Kwaan's research subjects integrate clinical and molecular perspectives on coagulation and fibrinolysis, especially in relation to COVID-19 and its complications. This includes investigation into the mechanisms of hypercoagulopathy in various SARS-CoV-2 variants and the role of hemostatic assays and fibrinolytic responses in critically ill patients.

Best Publications

  • Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine: A Review of 60 Cases

    Charles L. Bennett;Peter D. Weinberg;Karine Rozenberg-Ben-Dror;Karine Rozenberg-Ben-Dror;Paul R. Yarnold

  • Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75.

    Leo R. Zacharski;William G. Henderson;Frederick R. Rickles;Walter B. Forman

  • The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin

    S Gately;P Twardowski;M S Stack;D L Cundiff

  • Increased platelet aggregation in diabetes mellitus.

    H C Kwaan;J A Colwell;J A Colwell;J A Colwell;S Cruz;S Cruz;S Cruz;N Suwanwela;N Suwanwela;N Suwanwela

  • Reassessing the hemostatic disorder associated with acute promyelocytic leukemia.

    Martin S. Tallman;Hau C. Kwaan

  • Effect of Warfarin on Survival in Small Cell Carcinoma of the Lung: Veterans Administration Study No. 75

    Leo R. Zacharski;William G. Henderson;Frederick R. Rickles;Walter B. Forman

  • Human Prostate Carcinoma Cells Express Enzymatic Activity That Converts Human Plasminogen to the Angiogenesis Inhibitor, Angiostatin

    Stephen Gately;Przemyslaw Twardowski;M. Sharon Stack;Matthew Patrick

  • The plasminogen-plasmin system in malignancy

    Hau C. Kwaan

  • Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.

    Gerald A. Soff;Judith Sanderowitz;Stephen Gately;Elaine Verrusio

  • The Plasminogen Activator System and Cancer

    Brandon McMahon;Hau C. Kwaan

  • Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study

    Maria B. Bernik;Hau C. Kwaan

  • Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis

    HC Kwaan;J Wang;K Svoboda;Paul Declerck

  • The Role of Plasminogen-Plasmin System in Cancer

    Hau C. Kwaan;Brandon McMahon

  • The coagulopathy of acute promyelocytic leukaemia revisited

    Eytan Stein;Brandon McMahon;Hau Kwaan;Jessica K. Altman

  • Effects of all‐trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia

    M. S. Tallman;P. Lefèbvre;R. M. Baine;M. Shoji;M. Shoji

  • Hyperviscosity in polycythemia vera and other red cell abnormalities.

    Hau C. Kwaan;Jun Wang

  • Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation.

    E. van der Pol;A. Sturk;T. van Leeuwen;R. Nieuwland

  • The hyperviscosity syndromes.

    Hau C. Kwaan;Hau C. Kwaan;Anurekha Bongu

  • Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration.

    Anaadriana Zakarija;Nicholas Bandarenko;Dilip K. Pandey;Amy Auerbach

  • A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo

    Yongjing Guo;Abd Al-Roof Higazi;Ani Arakelian;Bruce S. Sachais

Frequent Co-Authors

Charles L. Bennett
Charles L. Bennett University of South Carolina
Martin S. Tallman
Martin S. Tallman Northwestern University
Thomas L. Ortel
Thomas L. Ortel Duke University
Miguel A. Sanz
Miguel A. Sanz University of Valencia
Francesco Lo-Coco
Francesco Lo-Coco University of Rome Tor Vergata
David Green
David Green Northwestern University
Charlotte M. Niemeyer
Charlotte M. Niemeyer University of Freiburg
Raul C. Ribeiro
Raul C. Ribeiro St. Jude Children's Research Hospital
Bob Löwenberg
Bob Löwenberg Erasmus MC
Leo I. Gordon
Leo I. Gordon Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a career in Medicine, there are many alternative educational routes to enter the healthcare field in the USA. For those interested in administrative roles, medical billing and coding schools online with financial aid offer flexible and affordable programs. These can be a great option if you want to quickly start working in healthcare without a medical degree.

Nursing continues to be a popular pathway. Not everyone has to take an entrance exam—find out do you have to take the teas test to get into nursing school to learn about schools that waive common admissions tests like TEAS or HESI. If advancing in healthcare administration interests you, explore the best online healthcare administration degree programs. These can help fast-track your leadership career in medical settings.

Registered nurses looking to move up should consider adn to msn bridge programs designed to accelerate progression from associate to master’s degrees. Each pathway offers unique benefits, making it easier to tailor your healthcare journey to your career goals.

Best Scientists Citing Hau C. Kwaan

Trending Scientists

Recently Published Articles